High dietary intake of sodium selenite does not affect gene mutation frequency in rat colon and liver

Biological Trace Element Research

Volumn 131, Issue 1, 2009, Pages 71-80

  Zeng, Huawei ^a   Uthus, Eric O ^a   Ross, Sharon A ^b   Davis, Cindy D ^b  

^a GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer; Colon; Gene mutation; Glutathione peroxidase; Selenium

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; DIMETHYLHYDRAZINE; DNA; GLUTATHIONE PEROXIDASE; SODIUM SELENITE; THIOREDOXIN REDUCTASE; CAENORHABDITIS ELEGANS PROTEIN; DIE 1 PROTEIN, C ELEGANS; DIE-1 PROTEIN, C ELEGANS; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BODY WEIGHT; COLON; COLON MUCOSA; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; ENZYME ACTIVITY; IN VIVO STUDY; LIVER; LIVER LEVEL; MUTATION RATE; NONHUMAN; PRECANCER; RAT; SOMATIC MUTATION; TRANSGENIC RAT; ANIMAL; CHEMICALLY INDUCED DISORDER; COLON TUMOR; DRUG EFFECT; GENETICS; IN VITRO STUDY; METABOLISM; MUTATION;

RATTUS;

ANIMALS; CAENORHABDITIS ELEGANS PROTEINS; COLON; COLONIC NEOPLASMS; DIMETHYLHYDRAZINES; GLUTATHIONE PEROXIDASE; LIVER; MUTATION; RATS; SODIUM SELENITE; TRANSCRIPTION FACTORS;

EID: 70350072463     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12011-009-8348-3     Document Type: Article

References (62)

1. C. B. Allan, G. M. Lacourciere, and T. C. Stadtman, Responsiveness of selenoproteins to dietary selenium, Annu Rev Nutr 19, 1-16 (1999).
2. C. Ip, Lessons from basic research in selenium and cancer prevention, J Nutr 128, 1845-1854 (1998).
3. K. El-Bayoumy, The protective role of selenium on genetic damage and on cancer, Mutat Res 475, 123-39 (2001).
4. G. F. Combs Jr., L. C. Clark, and B. W. Turnbull, An analysis of cancer prevention by selenium, Biofactors 14, 153-9 (2001).
5. P. D. Whanger, Selenium and its relationship to cancer: an update, Br J Nutr 91, 11-28 (2004).
6. G. F. Combs Jr., Current evidence and research needs to support a health claim for selenium and cancer prevention, J Nutr 135, 343-7 (2005).
7. C. Ip, Y. Dong, and H. E. Ganther, New concepts in selenium chemoprevention, Cancer Metastasis Rev 21, 281-9 (2002).
8. J. Lu and C. Jiang, Selenium and cancer chemoprevention: hypotheses integrating the actions of selenoproteins and selenium metabolites in epithelial and non-epithelial target cells, Antioxid Redox Signal 7, 1715-27 (2005).
9. P. Hasty, The impact of DNA damage, genetic mutation and cellular responses on cancer prevention, longevity and aging: observations in humans and mice, Mech Ageing Dev 126, 71-7 (2005).
10. Y. Hu, R. V. Benya, R. E. Carroll, and A. M. Diamond, Allelic loss of the gene for the GPX1 selenium- containing protein is a common event in cancer, J Nutr 135, 3021S-3024S (2005).
11. Y. P. Yu, G. Yu, G. Tseng, K. Cieply, J. Nelson, M. Defrances, R. Zarnegar, G. Michalopoulos, and J. H. Luo, Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis, Cancer Res 67, 8043-50 (2007).
12. J. E. Spallholz, V. P. Palace, and T. W. Reid, Methioninase and selenomethionine but not Se- methylselenocysteine generate methylselenol and superoxide in an in vitro chemiluminescent assay: implications for the nutritional carcinostatic activity of selenoamino acids, Biochem Pharmacol 67, 547-54 (2004).
13. M. Kaeck, J. Lu, R. Strange, C. Ip, H. E. Ganther, and H. J. Thompson, Differential induction of growth arrest inducible genes by selenium compounds, Biochem Pharmacol 53, 921-6 (1997).
14. Y. Dong, H. Zhang, L. Hawthorn, H. E. Ganther, and C. Ip, Delineation of the molecular basis for selenium-induced growth arrest in human prostate cancer cells by oligonucleotide array, Cancer Res 63, 52-9 (2003).
15. C. Ip and D. J. Lisk, Modulation of phase I and phase II xenobiotic-metabolizing enzymes by selenium- enriched garlic in rats, Nutr Cancer 28, 184-8 (1997).
16. D. J. Waters, S. Shen, D. M. Cooley, D. G. Bostwick, J. Qian, G. F. Combs Jr., L. T. Glickman, C. Oteham, D. Schlittler, and J. S. Morris, Effects of dietary selenium supplementation on DNA damage and apoptosis in canine prostate, J Natl Cancer Inst 95, 237-41 (2003).
17. D. J. Waters, S. Shen, L. T. Glickman, D. M. Cooley, D. G. Bostwick, J. Qian, G. F. Combs Jr., and J. S. Morris, Prostate cancer risk and DNA damage: translational significance of selenium supplementation in a canine model, Carcinogenesis 26, 1256-62 (2005).
18. N. Karunasinghe, J. Ryan, J. Tuckey, J. Masters, M. Jamieson, L. C. Clarke, J. R. Marshall, and L. R. Ferguson, DNA stability and serum selenium levels in a high-risk group for prostate cancer, Cancer Epidemiol Biomark Prev 13, 391-7 (2004).
19. E. Kowalska, S. A. Narod, T. Huzarski, S. Zajaczek, J. Huzarska, B. Gorski, and J. Lubinski, Increased rates of chromosome breakage in BRCA1 carriers are normalized by oral selenium supplementation, Cancer Epidemiol Biomark Prev 14, 1302-6 (2005).
20. R. P. Bird, Role of aberrant crypt foci in understanding the pathogenesis of colon cancer, Cancer Lett 93, 55-71 (1995).
21. G. Caderni, A. Giannini, L. Lancioni, C. Luceri, A. Biggeri, and P. Dolara, Characterisation of aberrant crypt foci in carcinogen-treated rats: association with intestinal carcinogenesis, Br J Cancer 71, 763-9 (1995).
22. L. Luo, B. Li, and T. P. Pretlow, DNA alterations in human aberrant crypt foci and colon cancers by random primed polymerase chain reaction, Cancer Res 63, 6166-9 (2003).
23. Y. Feng, J. W. Finley, C. D. Davis, W. K. Becker, A. J. Fretland, and D. W. Hein, Dietary selenium reduces the formation of aberrant crypts in rats administered 3, 2'-dimethyl-4-aminobiphenyl, Toxicol Appl Pharmacol 157, 36-42 (1999). (Pubitemid 29250251)
24. C. D. Davis, Y. Feng, D. W. Hein, and J. W. Finley, The chemical form of selenium influences 3, 2'- dimethyl-4-aminobiphenyl-DNA adduct formation in rat colon, J Nutr 129, 63-9 (1999).
25. C. D. Davis and E. O. Uthus, Dietary selenium and azadeoxycytidine treatment affect dimethylhydrazine-induced aberrant crypt formation in rat colon and DNA methylation in HT-29 cells, J Nutr 132, 292-297 (2002).
26. E. O. Uthus and S. A. Ross, Dietary selenium affects homocysteine metabolism differently in Fisher-344 rats and CD-1 mice, J Nutr 137, 1132-6 (2007).
27. P. G. Reeves, F. H. Nielsen, and G. C. Fahey Jr., AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet, J Nutr 123, 1939-51 (1993).
28. P. G. Reeves, Components of the AIN-93 diets as improvements in the AIN-76A diet, J Nutr 127, 838S-841S (1997).
29. J. W. Finley, L. Mathys, T. Shuler, and E. Korynta, Selenium contents of food purchased in North Dakota, Nutr Res 16, 723-728 (1996).
30. D. Paglia and W. Valentine, Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase, J Lab Clin Med 70, 158-169 (1967).
31. A. Holmgren and M. Bjornstedt, Thioredoxin and thioredoxin reductase, Methods Enzymol 252, 199-208 (1995).
32. K. E. Hill, G. W. McCollum, and R. F. Burk, Determination of thioredoxin reductase activity in rat liver supernatant, Anal Biochem 253, 123-5 (1997).
33. K. M. Pozharisski, Morphology and morphogenesis of experimental epithelial tumors of the intestine, J Natl Cancer Inst 54, 1115-35 (1975).
34. E. S. Fiala, Investigations into the metabolism and mode of action of the colon carcinogens 1, 2- dimethylhydrazine and azoxymethane, Cancer 40, 2436-45 (1977).
35. C. S. Potten, Y. Q. Li, P. J. O'Connor, and D. J. Winton, A possible explanation for the differential cancer incidence in the intestine, based on distribution of the cytotoxic effects of carcinogens in the murine large bowel, Carcinogenesis 13, 2305-12 (1992).
36. A. Likhachev, A. S. Petrov, L. G. P' Rvanova, and K. M. Pozharisskii, Mechanism of methylation of DNA bases by symmetrical dimethylhydrazine, Bull Exper Biol Med 86, 1604-1606 (1978).
37. A. C. Povey, A. F. Badawi, D. P. Cooper, C. N. Hall, K. L. Harrison, P. E. Jackson, N. P. Lees, P. J. O'Connor, and G P Margison, DNA alkylation and repair in the large bowel: animal and human studies, J Nutr 132, 3518S-3521S (2002).
38. J. M. Gee, H. Hara, and I. T. Johnson, Suppression of intestinal crypt cell proliferation and aberrant crypt foci by dietary quercetin in rats, Nutr Cancer 43, 193-201 (2002).
39. E. I. Salim and S. Fukushima, Chemopreventive potential of volatile oil from black cumin (Nigella sativa L.) seeds against rat colon carcinogenesis, Nutr Cancer 45, 195-202 (2003).
40. T. K. Smith, R. Mithen, and I. T. Johnson, Effects of Brassica vegetable juice on the induction of apoptosis and aberrant crypt foci in rat colonic mucosal crypts in vivo, Carcinogenesis 24, 491-5 (2003).
41. M. Ravnik-Glavac, A. Cerar, and D. Glavac, Animal model in the study of colorectal carcinogenesis, Pflugers Arch 440, R55-7 (2000).
42. A. Tomasi, E. Albano, B. Botti, and V. Vannini, Detection of free radical intermediates in the oxidative metabolism of carcinogenic hydrazine derivatives, Toxicol Pathol 15, 178-83 (1987).
43. Y. Sun, Free radicals, antioxidant enzymes, and carcinogenesis, Free Radic Biol Med 8, 583-99 (1990).
44. M. Sengottuvelan and N. Nalini, Dietary supplementation of resveratrol suppresses colonic tumour incidence in 1, 2-dimethylhydrazine-treated rats by modulating biotransforming enzymes and aberrant crypt foci development, Br J Nutr 96, 145-53 (2006).
45. M. Sengottuvelan, P. Viswanathan, and N. Nalini, Chemopreventive effect of trans-resveratrol-a phytoalexin against colonic aberrant crypt foci and cell proliferation in 1, 2-dimethylhydrazine induced colon carcinogenesis, Carcinogenesis 27, 1038-46 (2006).
46. K. Felix, S. Gerstmeier, A. Kyriakopoulos, O. M. Howard, H. F. Dong, M. Eckhaus, D. Behne, G. W. Bornkamm, and S. Janz, Selenium deficiency abrogates inflammation-dependent plasma cell tumors in mice, Cancer Res 64, 2910-7 (2004).
47. R. Irons, B. A. Carlson, D. L. Hatfield, and C. D. Davis, Both selenoproteins and low molecular weight selenocompounds reduce colon cancer risk in mice with genetically impaired selenoprotein expression, J Nutr 136, 1311-7 (2006).
48. V. Diwadkar-Navsariwala, G. S. Prins, S. M. Swanson, L. A. Birch, V. H. Ray, S. Hedayat, D. L. Lantvit, and A. M. Diamond, Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model, Proc Natl Acad Sci U S A 103, 8179-84 (2006).
49. G. F. Combs Jr., Chemopreventive mechanisms of selenium, Med Klin 94 Suppl 3, 18-24 (1999).
50. M. Berggren, A. Gallegos, J. Gasdaska, and G. Powis, Cellular thioredoxin reductase activity is regulated by selenium, Anticancer Res 17, 3377-80 (1997).
51. L. V. Papp, J. Lu, A. Holmgren, and K. K. Khanna, From selenium to selenoproteins: synthesis, identity, and their role in human health, Antioxid Redox Signal 9, 775-806 (2007).
52. J. E. Spallholz, Free radical generation by selenium compounds and their prooxidant toxicity, Biomed Environ Sci 10, 260-70 (1997).
53. M. S. Stewart, R. L. Davis, L. P. Walsh, and B. C. Pence, Induction of differentiation and apoptosis by sodium selenite in human colonic carcinoma cells (HT29), Cancer Lett 117, 35-40 (1997).
54. M. P. Rayman, Selenium in cancer prevention: a review of the evidence and mechanism of action, Proc Nutr Soc 64, 527-42 (2005).
55. H. J. Helbock, K. B. Beckman, M. K. Shigenaga, P. B. Walter, A. A. Woodall, H. C. Yeo, and B. N. Ames, DNA oxidation matters: the HPLC-electrochemical detection assay of 8-oxo-deoxyguanosine and 8-oxo-guanine, Proc Natl Acad Sci U S A 95, 288-93 (1998).
56. D. J. Howard, R. B. Ota, L. A. Briggs, M. Hampton, and C. A. Pritsos, Oxidative stress induced by environmental tobacco smoke in the workplace is mitigated by antioxidant supplementation, Cancer Epidemiol Biomark Prev 7, 981-8 (1998).
57. R. W. Welch, E. Turley, S. F. Sweetman, G. Kennedy, A. R. Collins, A. Dunne, M. B. Livingstone, P. G. McKenna, V. J. McKelvey-Martin, and J. J. Strain, Dietary antioxidant supplementation and DNA damage in smokers and nonsmokers, Nutr Cancer 34, 167-72 (1999).
58. Y. J. Sung, C. C. Juan, H. C. Lee, P. H. Yin, C. W. Chi, H. H. Ku, A. F. Li, Y. H. Wei, and H. J. Tsay, Oxidative stress is insignificant in N1S1-transplanted hepatoma despite markedly declined activities of the antioxidant enzymes, Oncol Rep 6, 1313-9 (1999).
59. C. L. Shen, W. Song, and B. C. Pence, Interactions of selenium compounds with other antioxidants in DNA damage and apoptosis in human normal keratinocytes, Cancer Epidemiol Biomark Prev 10, 385-90 (2001).
60. B. J. Wycherly, M. A. Moak, and M. J. Christensen, High dietary intake of sodium selenite induces oxidative DNA damage in rat liver, Nutr Cancer 48, 78-83 (2004).
61. S. Boiteux and J. P. Radicella, Base excision repair of 8-hydroxyguanine protects DNA from endogenous oxidative stress, Biochimie 81, 59-67 (1999).
62. S. Samanta, V. Swamy, D. Suresh, M. Rajkumar, B. Rana, A. Rana, and M. Chatterjee, Protective effects of vanadium against DMH-induced genotoxicity and carcinogenesis in rat colon: removal of O(6)-methylguanine DNA adducts, p53 expression, inducible nitric oxide synthase downregulation and apoptotic induction, Mutat Res 650, 123-31 (2008).